Search Results - "Kotzé, Awie F."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Beneficial Pharmacokinetic Drug Interactions: A Tool to Improve the Bioavailability of Poorly Permeable Drugs by Gerber, Werner, Steyn, Johan D, Kotzé, Awie F, Hamman, Josias H

    Published in Pharmaceutics (26-07-2018)
    “…Simultaneous oral intake of herbs, supplements, foods and drugs with other drug(s) may result in pharmacokinetic or pharmacodynamic interactions with the…”
    Get full text
    Journal Article
  2. 2

    Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets by Viljoen, Joe M., Steenekamp, Jan H., Marais, Andries F., Kotzé, Awie F.

    Published in Drug development and industrial pharmacy (01-06-2014)
    “…Abstract Context: Chitosan does not rank highly regarding its employment as tablet filler due to certain limitations. Undesirable properties that limit its…”
    Get full text
    Journal Article
  3. 3

    Oral delivery of peptide drugs: barriers and developments by Hamman, Josias H, Enslin, Gill M, Kotzé, Awie F

    “…A wide variety of peptide drugs are now produced on a commercial scale as a result of advances in the biotechnology field. Most of these therapeutic peptides…”
    Get full text
    Journal Article
  4. 4

    Formulation and evaluation of Pheroid vesicles containing mefloquine for the treatment of malaria by du Plessis, Lissinda H., Helena, Chrizaan, van Huysteen, Este, Wiesner, Lubbe, Kotzé, Awie F.

    Published in Journal of pharmacy and pharmacology (01-01-2014)
    “…Objectives Mefloquine (MQ) is an antimalarial drug with high efficacy, often used in the treatment and chemoprophylaxis of malaria. However, it has low…”
    Get full text
    Journal Article
  5. 5

    Applications of lipid based formulation technologies in the delivery of biotechnology-based therapeutics by du Plessis, Lissinda H, Marais, Etienne B, Mohammed, Faruq, Kotzé, Awie F

    Published in Current pharmaceutical biotechnology (01-01-2014)
    “…In the last decades several new biotechnologically-based therapeutics have been developed due to progress in genetic engineering. A growing challenge facing…”
    Get more information
    Journal Article
  6. 6

    In vitro activity of Pheroid vesicles containing antibiotics against Plasmodium falciparum by Du Plessis, Lissinda H, van Niekerk, Anel C, Maritz, Marlene M, Kotzé, Awie F

    Published in Journal of antibiotics (01-12-2012)
    “…The macrolide antibiotics, erythromycin and azithromycin, have been studied for their potential antimalarial activity, but only modest activity has been…”
    Get full text
    Journal Article
  7. 7

    Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride by du Plessis, Lissinda H, Kotzé, Awie F, Junginger, Hans E

    Published in Drug delivery (01-08-2010)
    “…The aim of this study was to evaluate the ability of TMC, with different degrees of quaternization, to increase insulin absorption in vivo following nasal and…”
    Get more information
    Journal Article
  8. 8

    Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2) by Kotzé, Awie F, Lueßen, Henrik L, de Leeuw, Bas J, de Boer, (A)Bert G, Coos Verhoef, J, Junginger, Hans E

    Published in Journal of controlled release (23-01-1998)
    “…A partially quaternized chitosan derivative, N-trimethyl chitosan chloride (TMC) (degree of quaternization 12.28%), was synthesized and the effects of this…”
    Get full text
    Journal Article
  9. 9

    Intestinal Drug Absorption Enhancers: Synergistic Effects of Combinations by Enslin, Gill M., Hamman, Josias H., Kotzé, Awie F.

    Published in Drug development and industrial pharmacy (01-01-2008)
    “…Although many absorption enhancers have been investigated, very few are used clinically. A need exists therefore for more effective absorption enhancers. The…”
    Get full text
    Journal Article
  10. 10

    Absorption of the novel artemisinin derivatives artemisone and artemiside: Potential application of Pheroid™ technology by Steyn, J. Dewald, Wiesner, Lubbe, du Plessis, Lissinda H., Grobler, Anne F., Smith, Peter J., Chan, Wing-Chi, Haynes, Richard K., Kotzé, Awie F.

    Published in International journal of pharmaceutics (29-07-2011)
    “…Artemisinins have low aqueous solubility that results in poor and erratic absorption upon oral administration. The poor solubility and erratic absorption…”
    Get full text
    Journal Article
  11. 11

    Direct compression of chitosan: process and formulation factors to improve powder flow and tablet performance by Buys, Gerhard M, du Plessis, Lissinda H, Marais, Andries F, Kotze, Awie F, Hamman, Josias H

    Published in Current drug delivery (01-06-2013)
    “…Chitosan is a polymer derived from chitin that is widely available at relatively low cost, but due to compression challenges it has limited application for the…”
    Get more information
    Journal Article
  12. 12

    Evaluation of the Mucoadhesive Properties of N-Trimethyl Chitosan Chloride by Snyman, Dewald, Hamman, Josias H., Kotze, Awie F.

    “…Abstract Previous studies have established that N-trimethyl chitosan chloride (TMC) is a potent absorption enhancer for peptides and large hydrophilic…”
    Get full text
    Journal Article
  13. 13

    N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces : In vitro evaluation in intestinal epithelial cells (Caco-2) by KOTZE, A. F, LUESSEN, H. L, DE LEEUW, B. J, DE BOER, A. B. G, VERHOEF, J. C, JUNGINGER, H. E

    Published in Pharmaceutical research (01-09-1997)
    “…Previous studies have established that chitosan hydrochloride and glutamate are potent absorption enhancers for large hydrophilic compounds across mucosal…”
    Get full text
    Journal Article
  14. 14

    Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2) by Kotzé, A F, Thanou, M M, Luebetaen, H L, de Boer, A G, Verhoef, J C, Junginger, H E

    Published in Journal of pharmaceutical sciences (01-02-1999)
    “…Previous studies have established that a partially quaternized derivative of chitosan, N-trimethyl chitosan chloride (TMC), can be used as an absorption…”
    Get more information
    Journal Article
  15. 15

    Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2) by Kotzé, Awie F, Thanou, Maya M, Lueßen, Henrik L, de Boer, (A)Bert G, Verhoef, J.Coos, Junginger, Hans E

    “…N-trimethyl chitosan chloride (TMC), a partially quaternized derivative of chitosan with superior water solubility, was synthesized with different degrees of…”
    Get full text
    Journal Article